Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Photocure ASA : Mandatory notification of trade

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2013 | 11:02am CET
Photocure ASA - Selling price of shares

Reference is made to the statement dated 15.03.2013. The payment has been determined based on a selling price of NOK 40.2584 per share.

After exercising options, Grete Hogstad holds 8 750 unexercised options in the Company, corresponding to 8 750 shares at the strike price of NOK 20.30. In addition she holds; 7
200 unexercised options, corresponding to 7 200 shares at the strike price of NOK 32.00;
23 400 unexercised options, corresponding to 23 400 shares at the strike price of NOK
44.00; and 17 250 unexercised options, corresponding to 17 250 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 10 500 shares in the Company.
After exercising options, Gry Stensrud holds 6 250 unexercised options in the Company, corresponding to 6 250 shares at the strike price of 20.30. In addition she holds; 19 050 unexercised options, corresponding to 19 050 shares at the strike price of NOK 44.00; and 22 500 unexercised options, corresponding to 22 500 shares at the strike price of NOK 50.75. After completion of the abovementioned transactions, the primary insider holds 6 shares in the Company.

For further information, please contact: Photocure

CFO Erik Dahl
Tel: +47 450 55 000, Email: ed@photocure.no

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PHOTOCURE ASA
12/08 PCI BIOTECH : PCIB - Disclosure of large shareholding
12/05 PHOTOCURE : US registry shows that Blue Light Cystoscopy (BLC) with Cysview®/Hex..
11/30 PHOTOCURE ASA : Share capital increase registered
11/28 PHOTOCURE ASA : Blue Light Cystoscopy (BLC) with Cysview®/Hexvix® decreases the ..
11/24 PHOTOCURE ASA : Update on management shareholdings and exercise of employee shar..
11/21 PHOTOCURE ASA : Strong recommendations for Blue Light Cystoscopy with Hexvix® in..
11/21 PHOTOCURE : Strong recommendations for Blue Light Cystoscopy with Hexvix® in new..
11/15 PHOTOCURE : Results for third quarter 2016
11/15 PHOTOCURE ASA : Results for third quarter 2016
11/14 PHOTOCURE : Presentation of the third quarter 2016 results
More news
Sector news : Pharmaceuticals - NEC
12/09 FTSE records best week since July, Sky surges 27 percent on Fox bid
12/09DJASTRAZENECA : FDA Accepts License Application for Durvalumab
12/09DJBayer Teams Up With Versant to Develop Stem-Cell Therapies--Update
12/08 BRISTOL MYERS SQUIBB : Meyers Squibb to pay $19.5 million to settle off-label pr..
12/07 MYLAN : EpiPen maker Mylan to restructure, cut workforce
More sector news : Pharmaceuticals - NEC
Advertisement
Financials ( NOK)
Sales 2016 135 M
EBIT 2016 -21,1 M
Net income 2016 6,36 M
Finance 2016 110 M
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 6,24x
EV / Sales 2017 5,49x
Capitalization 952 M
More Financials
Chart PHOTOCURE ASA
Duration : Period :
Photocure ASA Technical Analysis Chart | PHO | NO0010000045 | 4-Traders
Full-screen chart
Technical analysis trends PHOTOCURE ASA
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 50,0  NOK
Spread / Average Target 13%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kjetil Hestdal President, Chief Executive Officer & Media Contact
Bente-Lill Bjerkelund Romøren Chairman
Erik Dahl Chief Financial Officer & IR Contact
Inger Ferner Heglund Vice President-Research & Development
Xavier Denis Yon Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PHOTOCURE ASA5.49%112
JOHNSON & JOHNSON9.29%305 407
ROCHE HOLDING LTD.-17.58%193 824
PFIZER INC.-4.15%192 367
NOVARTIS AG-18.49%182 959
MERCK & CO., INC.15.92%168 820
More Results